
LEO Pharma’s topical medication was shown to be safe and effective in adult patients with moderate-to-severe hand eczema.
LEO Pharma’s topical medication was shown to be safe and effective in adult patients with moderate-to-severe hand eczema.
The risk of untreated depression for pregnant women can cause adverse outcomes, which can include relapse in mood symptoms, suicide, and overdose death.
Women with premature ovarian insufficiency experience a high prevalence of depressive symptoms, highlighting the need for comprehensive, multidisciplinary care.
Amid uncertainty about the best factors for measuring and defining pharmacy deserts, researchers explored the impacts of drive time and inequities in pharmacy access.
Pharmacists can improve insulin safety and adherence by combining in-person counseling with practical tools, regular check-ins, and proactive education.
Michael Murphy, PharmD, MBA, provided insights on his research regarding pharmacy deserts, who they impact the most, and the methods needed to improve them in the US.
Addressing harassment, strengthening leadership, and involving frontline pharmacy staff in decision-making are key steps toward a healthier, more supportive work environment.
Flu vaccination significantly reduces illness in vaccinated and unvaccinated individuals, highlighting its importance in public health strategies.
From 2008 to 2023, the relative increase of pediatric patients with obesity classes 4 to 5 was 253.1%.
With an emphasis on the factors that differentiate the future roles of pharmacists, researchers sought to better understand the career intentions of pharmacy students.
Pharmacists play a key role in monitoring insulin use by addressing dosing, storage, and symptom management through regular, supportive patient check-ins.
The FDA approves Kirsty, an interchangeable biosimilar insulin, enhancing diabetes treatment options and accessibility for patients.
Community pharmacists play a crucial role in helping patients start insulin with confidence through education, emotional support, and hands-on guidance.
Using the Q Methodology to account for subjectivity in responses, pharmacists self-identified their professional identities.
New study data reveal the waning effectiveness of 2023-2024 COVID-19 vaccines, highlighting the need for ongoing vaccinations and pharmacist involvement.
Older adults with insomnia face heightened depression risks during inflammation, highlighting the need for targeted monitoring and treatment strategies.
In the researchers’ exploration of post-ICU nutritional care, they detailed the clinical pharmacist’s role and provided insights into how this role may evolve in the future.
Emphasizing the pharmacist’s essential role, researchers explored the causes, consequences, and clinical implications of polypharmacy.
This year’s conference is taking place from August 1 to 4 in Cincinnati, Ohio.
The new presentation of Shingrix will allow for easier administration.
Brooklyn Morgan, PharmD, discusses the transformation of pharmacy practice from a regulatory model to a more flexible approach.
Researchers conducted a review of pharmacist interventions and their ability to impact the outcomes of patients with COPD.
The 2 corporations formed the Bristol Myers Squibb-Pfizer Alliance and will be offering discounted Eliquis to eligible patients starting September 8, 2025.
Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM, discusses how pharmacists can collaborate with providers to optimize insulin therapy.
Thomas Sherrer, PharmD, emphasizes teamwork and technology in inventory management to enhance patient safety and reduce medication errors.
Researchers examined the factors attributed to self-reported resilience among diverse and community-dwelling adults during the COVID-19 pandemic.
Investigators find that the phase 2 trial supports the further development of MK-8527 as an HIV pre-exposure prophylaxis.
New research findings reveal amoxicillin's effectiveness varies in treating invasive pneumococcal disease, highlighting the importance of patient-specific factors in antibiotic therapy.
Researchers characterized trends in COVID-19 hospitalizations by race and ethnicity among children from March 2020 to September 2023.
Older adults are more likely to have chronic diseases, such as lung or heart disease, which makes them more susceptible to invasive pneumococcal disease.